UB researchers found that more than 90 % of those in the telemedicine arm at an opioid treatment program were cured of HCV infection compared to 35.2% of participants referred to an offsite specialist.
The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo has received a $40,000 grant from the Alliance for Academic Internal Medicine (AAIM) for a novel addition to its internal medicine residency program.
Thirty-two faculty members with a variety of clinical and research experience — representing 12 medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.
The multitude of cancer research studies being conducted at the University at Buffalo was on full display at the UB Cancer Research Consortium Symposium.
A researcher who focuses on mind-body modalities as treatments for migraine headaches was the featured speaker at the 21st annual Lawrence & Nancy Golden Memorial Lectureship on Mind-Body Medicine.
UBMD Internal Medicine has opened Western New York’s first Long COVID Center. Funded by a grant from the Mother Cabrini Health Foundation with support from the University at Buffalo, the center is accepting all patients, whether they have insurance or not.
Kenneth E. Leonard, PhD, director of UB’s Clinical and Research Institute on Addictions, has been appointed to the Program Advisory Board of the National Consortium on Alcohol and Neurodevelopment in Adolescent-Adulthood (NCANDA-A).
Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.
